Intercure Ltd. Ordinary Shares (INCR)
Intercure Ltd. (INCR) is a biotech company focused on the development and commercialization of cannabis-based products and therapies. It operates through its subsidiaries, engaging in research, cultivation, extraction, and distribution within the medical cannabis industry. The company aims to provide high-quality medicinal cannabis solutions, leveraging innovative formulations to address various health conditions.
Company News
InterCure Ltd. announced its acquisition of Botanico Ltd. (ISHI), gaining access to advanced AI-driven cultivation technologies and exclusive US cannabis brand partnerships, positioning itself for potential industry expansion amid potential cannabis rescheduling.
InterCure reported revenue of NIS 126 million and adjusted EBITDA of NIS 21 million for the first half of 2024. The company's southern facility was affected by a terrorist attack and the war in Gaza, but it is entitled to compensation from the Israeli authorities. InterCure plans to expand its partnership with Cookies and launch products in Germa...